| TABLE OF CONTENTS | ||||||||||||||||||||||||||||||||||||||
| August 2014 Volume 10 Number 8 | ||||||||||||||||||||||||||||||||||||||
In this issue
| ||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||
| Advertisement | ||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||
| NEWS AND VIEWS | Top | |||||||||||||||||||||||||||||||||||||
| Transplantation: CNIs to mTOR inhibitors—effects on allosensitization? Aditi Gupta & Bruce Kaplan Published online: 27 May 2014 p425 | doi:10.1038/nrneph.2014.94 Pre-existing HLA antibodies negatively impact long-term graft survival and might be a major risk factor for the formation of new HLA antibodies. Whether conversion of transplant recipients from calcineurin inhibitors to mammalian target of rapamycin inhibitors increases the risk of allosensitization remains to be determined. Full Text | PDF | ||||||||||||||||||||||||||||||||||||||
| Clinical trials: ISN-ACCTS: global initiatives to improve clinical research Adeera Levin & Giuseppe Remuzzi Published online: 10 June 2014 p426 | doi:10.1038/nrneph.2014.98 The International Society of Nephrology-Advisory Committee of Clinical Trials and Studies aims to ensure access to timely and unbiased expert advice for all investigators, and to facilitate the development and execution of clinical trials within a highly ethical framework. The initiative will foster high-quality, cost-effective research in a sustainable network. Full Text | PDF | ||||||||||||||||||||||||||||||||||||||
| Chronic kidney disease: Prenatal risk factors for kidney and urinary tract anomalies Robert H. Mak & Franz Schaefer Published online: 17 June 2014 p428 | doi:10.1038/nrneph.2014.105 Childhood-onset chronic kidney disease is the result of congenital anomalies of the kidneys and urinary tract in approximately two-thirds of all patients. An area of intense research in recent years, however, is the potential impact of maternal obesity on renal ontogenesis or postnatal renal function in the offspring. Full Text | PDF | ||||||||||||||||||||||||||||||||||||||
| Transplantation: Molecular diagnosis of kidney transplant rejection Christian Morath & Martin Zeier Published online: 17 June 2014 p429 | doi:10.1038/nrneph.2014.106 Acute or chronic antibody-mediated rejection (ABMR) of kidney allografts is currently diagnosed by the presence of donor-specific alloantibodies and distinct pathological findings in biopsy samples. A new study highlights the potential of molecular diagnostics incorporated into standard criteria for acute ABMR to help identify patients at risk of graft loss. Full Text | PDF | ||||||||||||||||||||||||||||||||||||||
| Glomerular disease: The search goes on: suPAR is not the elusive FSGS factor Jeroen K. Deegens & Jack F. Wetzels Published online: 24 June 2014 p431 | doi:10.1038/nrneph.2014.113 New research indicates that intact soluble urokinase plasminogen activator receptor (suPAR) does not induce albuminuria in mice. These data corroborate the most recent clinical findings, showing that intact suPAR is not the plasma permeability factor responsible for recurrence of focal segmental glomerulosclerosis after renal transplantation. Full Text | PDF | ||||||||||||||||||||||||||||||||||||||
| REVIEWS | Top | |||||||||||||||||||||||||||||||||||||
| Next-generation sequencing for research and diagnostics in kidney disease Kirsten Y. Renkema, Marijn F. Stokman, Rachel H. Giles & Nine V. A. M. Knoers Published online: 10 June 2014 p433 | doi:10.1038/nrneph.2014.95 The introduction of next-generation sequencing has provided revolutionary opportunities for comprehensive genetic testing in research and diagnostics. Here, the authors discuss approaches used for novel gene identification, the potential of these techniques to improve the management of patients with inherited kidney diseases—focusing on nephronophthisis and congenital anomalies of the kidney and urinary tract—and the remaining challenges for implementation of next-generation sequencing in clinical practice. Abstract | Full Text | PDF | ||||||||||||||||||||||||||||||||||||||
| Pathology of IgA nephropathy Ian S. D. Roberts Published online: 27 May 2014 p445 | doi:10.1038/nrneph.2014.92 In this Review, Ian Roberts provides a detailed description of the immunohistology and light microscopical features of IgA nephropathy, and highlights the importance of accurate recognition of the various histological lesions for reproducible classification of the disease. The different schemas used for classifying IgA nephropathy are compared, with particular focus on the Oxford classification. Abstract | Full Text | PDF | ||||||||||||||||||||||||||||||||||||||
| Renal transplantation in autosomal dominant polycystic kidney disease Nada Kanaan, Olivier Devuyst & Yves Pirson Published online: 17 June 2014 p455 | doi:10.1038/nrneph.2014.104 Renal transplantation is the preferred treatment option for patients with autosomal dominant polycystic kidney disease (ADPKD) and end-stage renal disease. Here, the authors discuss special considerations for pretransplant screening and living-related kidney donation in patients with ADPKD, as well as post-transplant outcomes and complications in these patients. Abstract | Full Text | PDF | ||||||||||||||||||||||||||||||||||||||
| Pre-eclampsia part 1: current understanding of its pathophysiology Tinnakorn Chaiworapongsa, Piya Chaemsaithong, Lami Yeo & Roberto Romero Published online: 08 July 2014 p466 | doi:10.1038/nrneph.2014.102 Several genetic and environmental factors have been implicated in pre-eclampsia, a rare but serious condition leading to maternal and perinatal morbidity and mortality. In the first of this two-part Review, Chaiworapongsa and colleagues discuss the pathophysiology of pre-eclampsia, including imbalance between angiogenic and antiangiogenic factors, which has emerged as the central pathogenetic mechanism. Abstract | Full Text | PDF | ||||||||||||||||||||||||||||||||||||||
| Advertisement | ||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||
| *Journal Citation Reports, Thomson, 2012. Nature Reviews Nephrology was previously published as Nature Clinical Practice Nephrology. |
You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/myaccount For further technical assistance, please contact our registration department For print subscription enquiries, please contact our subscription department For other enquiries, please contact our feedback department Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2014 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. |
No comments:
Post a Comment
Keep a civil tongue.